109 related articles for article (PubMed ID: 25080072)
1. New perspectives on using brain imaging to study CNS stimulants.
Lukas SE
Neuropharmacology; 2014 Dec; 87():104-14. PubMed ID: 25080072
[TBL] [Abstract][Full Text] [Related]
2. Functional imaging and neurochemical correlates of stimulant self-administration in primates.
Howell LL; Wilcox KM
Psychopharmacology (Berl); 2002 Oct; 163(3-4):352-61. PubMed ID: 12373436
[TBL] [Abstract][Full Text] [Related]
3. Structural plasticity of the brain to psychostimulant use.
Nyberg F
Neuropharmacology; 2014 Dec; 87():115-24. PubMed ID: 25018041
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of stimulant misuse and abuse: implications for future epidemiologic and neuropharmacologic research.
Gerlach KK; Dasgupta N; Schnoll SH; Henningfield JE
Neuropharmacology; 2014 Dec; 87():91-6. PubMed ID: 24813641
[TBL] [Abstract][Full Text] [Related]
5. Brain mechanisms of drug reward and euphoria.
Wise RA; Bozarth MA
Psychiatr Med; 1985; 3(4):445-60. PubMed ID: 2893431
[TBL] [Abstract][Full Text] [Related]
6. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.
Chang L; Alicata D; Ernst T; Volkow N
Addiction; 2007 Apr; 102 Suppl 1():16-32. PubMed ID: 17493050
[TBL] [Abstract][Full Text] [Related]
7. Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine.
Heal DJ; Gosden J; Smith SL
Neuropharmacology; 2014 Dec; 87():19-40. PubMed ID: 24953830
[TBL] [Abstract][Full Text] [Related]
8. Designer psychostimulants: pharmacology and differences.
Iversen L; White M; Treble R
Neuropharmacology; 2014 Dec; 87():59-65. PubMed ID: 24456744
[TBL] [Abstract][Full Text] [Related]
9. Human abuse liability evaluation of CNS stimulant drugs.
Romach MK; Schoedel KA; Sellers EM
Neuropharmacology; 2014 Dec; 87():81-90. PubMed ID: 24793872
[TBL] [Abstract][Full Text] [Related]
10. Addictiveness of central stimulants.
Dackis CA; Gold MS
Adv Alcohol Subst Abuse; 1990; 9(1-2):9-26. PubMed ID: 1974121
[TBL] [Abstract][Full Text] [Related]
11. Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use.
Aron JL; Paulus MP
Addiction; 2007 Apr; 102 Suppl 1():33-43. PubMed ID: 17493051
[TBL] [Abstract][Full Text] [Related]
12. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
Seger D
Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system stimulants: neuropharmacological mechanisms.
Nielsen EB; Scheel-Krüger J
Psychopharmacol Ser; 1988; 4():57-72. PubMed ID: 2899318
[TBL] [Abstract][Full Text] [Related]
14. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
15. Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine.
O'Shea E; Urrutia A; Green AR; Colado MI
Neuropharmacology; 2014 Dec; 87():125-34. PubMed ID: 24594477
[TBL] [Abstract][Full Text] [Related]
16. Psychostimulants and brain dysfunction: a review of the relevant neurotoxic effects.
Gonçalves J; Baptista S; Silva AP
Neuropharmacology; 2014 Dec; 87():135-49. PubMed ID: 24440369
[TBL] [Abstract][Full Text] [Related]
17. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
Camacho A; Akiskal HS
J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
[TBL] [Abstract][Full Text] [Related]
18. Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine.
Müller CP; Huston JP
Trends Pharmacol Sci; 2006 Feb; 27(2):105-12. PubMed ID: 16406129
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional neuroimaging studies of the suicidal brain.
Desmyter S; van Heeringen C; Audenaert K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):796-808. PubMed ID: 21216267
[TBL] [Abstract][Full Text] [Related]
20. Cocaine addiction as a neurological disorder: implications for treatment.
Majewska MD
NIDA Res Monogr; 1996; 163():1-26. PubMed ID: 8809851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
